Copy number variation sequencing for the products of conception : What is the optimal testing strategy
Copyright © 2024 Elsevier B.V. All rights reserved..
BACKGROUND: Copy number variation sequencing (CNV-seq) is crucial in prenatal diagnosis, but its limitations in detecting polyploidy, maternal cell contamination (MCC), and uniparental disomy (UPD) restrict its application in the analysis of products of conception (POCs). This study aimed to investigate an optimal genetic testing strategy for POCs in the era of CNV-seq.
METHODS: CNV-seq and quantitative fluorescent polymerase chain reaction (QF-PCR) were performed in all 4,211 spontaneous miscarriage cases. Different testing strategies were compared and the optimal testing strategies were proposed.
RESULTS: Of the 4,211 cases, 2561 (60.82%) exhibited clinically significant chromosomal abnormalities. CNV-seq alone, without QF-PCR, might misdiagnose 311 (7.39%) cases, including 278 polyploidy, 13 UPD, and 20 MCC. In 20 MCC cases identified by QF-PCR, CNV-seq successfully pinpointed the cause of miscarriage in 13 cases. Furthermore, in cases where QF-PCR suggested polyploidy, CNV-seq improved the diagnostic accuracy in 54 (1.28%) hypo/hypertriploidy cases. After comparing four different strategies, the sequential approach (initiating with CNV-seq followed by QF-PCR if necessary) emerged as advantageous, reducing approximately 70% of the cost associated with QF-PCR while maintaining result accuracy.
CONCLUSIONS: We propose an initial CNV-seq followed by QF-PCR if needed-an efficient and cost-effective strategy for the genetic analysis of POCs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:557 |
|---|---|
| Enthalten in: |
Clinica chimica acta; international journal of clinical chemistry - 557(2024) vom: 15. Apr., Seite 117884 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Chen, Yiyao [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Copy number variation sequencing |
|---|
| Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cca.2024.117884 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370123921 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370123921 | ||
| 003 | DE-627 | ||
| 005 | 20240415233536.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240325s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cca.2024.117884 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM370123921 | ||
| 035 | |a (NLM)38522821 | ||
| 035 | |a (PII)S0009-8981(24)00125-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Chen, Yiyao |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Copy number variation sequencing for the products of conception |b What is the optimal testing strategy |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: Copy number variation sequencing (CNV-seq) is crucial in prenatal diagnosis, but its limitations in detecting polyploidy, maternal cell contamination (MCC), and uniparental disomy (UPD) restrict its application in the analysis of products of conception (POCs). This study aimed to investigate an optimal genetic testing strategy for POCs in the era of CNV-seq | ||
| 520 | |a METHODS: CNV-seq and quantitative fluorescent polymerase chain reaction (QF-PCR) were performed in all 4,211 spontaneous miscarriage cases. Different testing strategies were compared and the optimal testing strategies were proposed | ||
| 520 | |a RESULTS: Of the 4,211 cases, 2561 (60.82%) exhibited clinically significant chromosomal abnormalities. CNV-seq alone, without QF-PCR, might misdiagnose 311 (7.39%) cases, including 278 polyploidy, 13 UPD, and 20 MCC. In 20 MCC cases identified by QF-PCR, CNV-seq successfully pinpointed the cause of miscarriage in 13 cases. Furthermore, in cases where QF-PCR suggested polyploidy, CNV-seq improved the diagnostic accuracy in 54 (1.28%) hypo/hypertriploidy cases. After comparing four different strategies, the sequential approach (initiating with CNV-seq followed by QF-PCR if necessary) emerged as advantageous, reducing approximately 70% of the cost associated with QF-PCR while maintaining result accuracy | ||
| 520 | |a CONCLUSIONS: We propose an initial CNV-seq followed by QF-PCR if needed-an efficient and cost-effective strategy for the genetic analysis of POCs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Copy number variation sequencing | |
| 650 | 4 | |a Products of conception | |
| 650 | 4 | |a Quantitative fluorescent polymerase chain reaction | |
| 650 | 4 | |a Spontaneous miscarriage | |
| 650 | 4 | |a Testing strategies | |
| 700 | 1 | |a Han, Xu |e verfasserin |4 aut | |
| 700 | 1 | |a Hua, Renyi |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Niu |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Lanlan |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Wenjing |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yanlin |e verfasserin |4 aut | |
| 700 | 1 | |a Qian, Zhida |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Shuyuan |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinica chimica acta; international journal of clinical chemistry |d 1956 |g 557(2024) vom: 15. Apr., Seite 117884 |w (DE-627)NLM000002054 |x 1873-3492 |7 nnns |
| 773 | 1 | 8 | |g volume:557 |g year:2024 |g day:15 |g month:04 |g pages:117884 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cca.2024.117884 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 557 |j 2024 |b 15 |c 04 |h 117884 | ||